The drug is currently being evaluated in two fully recruited global Phase 3 studies for progressive and tophaceous gout, with results expected in 2026.
ABP-745 is a novel oral therapy with potential applications in cardiovascular and other inflammatory diseases
LG Chem will receive totaling up to $95.5 million for the China rights
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
The company reported total income at Rs. 509.8 crore in Q1 FY25 as compared to Rs. 570.3 crore in Q1 FY24
EDQM has also issued a Certificate of Suitability for Allopurino
Colchicine Capsules are indicated for prophylaxis of gout flares in adult
Febuxostat Tablets (RLD Uloric) had estimated annual sales of US$ 27 million in the U.S. (IQVIA MAT November 2023)
Five batches across four programs of Biocon Academy participated in the graduation ceremony
The product will be manufactured at Lupin's Pithampur facility in India
Subscribe To Our Newsletter & Stay Updated
